Results 311 to 320 of about 1,293,835 (325)

Risk factors and effectiveness of vaccination for nosocomial SARS-CoV-2 acquisition throughout the SARS-CoV-2 pandemic. [PDF]

BMC Infect Dis
Dave N, van der Werff SD, Sjöholm D, Zetterqvist J, Nauclér P.   +4 more
europepmc   +1 more source

Adipose Tissue in SARS‐CoV‐2 Viral Tropism, Viral Replication, and the Concept of a Viral Reservoir: An Update

Obesity, EarlyView.
Adipose tissue as a potential reservoir for and modifier of SARS‐CoV‐2 infection and its complications. Schematic demonstrating the differences in subcutaneous and visceral adipose tissue and infection capacity of SARS‐CoV‐2 with interplay between macrophages and adipocytes as target cells for viral tropism.
Liam Charles Maher, Paul M. Ryan, Noel M. Caplice   +2 more
wiley   +1 more source

Humoral epitope dominance and immune imprinting by SARS-CoV-1 and SARS-CoV-2 vaccines. [PDF]

Immunol Cell Biol
Burnett DL, Moxon A, Aggarwal A, Jackson KJ, Cotter C, Akerman A, Russell A, Kalman R, Langley D, Henry JY, Christ D, Bull RA, Brink R, Kelleher AD, Jäck HM, Turville S, Moss B, Goodnow CC.   +17 more
europepmc   +1 more source

The Mac1 ADP-ribosylhydrolase is a therapeutic target for SARS-CoV-2. [PDF]

Elife
Suryawanshi RK, Jaishankar P, Correy GJ, Rachman MM, O'Leary PC, Taha TY, Matsui Y, Zapatero-Belinchón FJ, McCavitt-Malvido M, Doruk YU, Stevens MGV, Diolaiti ME, Jogalekar MP, Chen H, Richards AL, Kongpracha P, Bali S, Montano M, Rosecrans J, Matthay M, Togo T, Gonciarz RL, Gopalkrishnan S, Neitz RJ, Krogan NJ, Swaney DL, Shoichet BK, Ott M, Renslo AR, Ashworth A, Fraser JS.   +30 more
europepmc   +1 more source

Beyond Pathology: α‐Synuclein Homeostasis and Three Principles to Guide Research

Movement Disorders Clinical Practice, EarlyView.
Alberto J. Espay, Andrew J. Lees
wiley   +1 more source

Resistance of endothelial cells to SARS-CoV-2 infection <i>in vitro</i>. [PDF]

J Virol
Ahmetaj-Shala B, Peacock TP, Baillon L, Swann OC, Gashaw H, Rustagi A, Barclay WS, Mitchell JA.   +7 more
europepmc   +1 more source

Finally neutralizing the threat? A novel SARS-CoV-2 vaccine platform that elicits enhanced neutralizing antibody responses

Daniel J. Salamango
openalex   +1 more source

Correction: Assessing the emergence time of SARS-CoV-2 zoonotic spillover. [PDF]

PLoS One
Samson S, Lord É, Makarenkov V.
europepmc   +1 more source

Application of the humanized mouse model in research into SARS-CoV-2 infection (Review). [PDF]

Med Int (Lond)
Feng X, Wang Y, Li Y, Long J, Liu F, Yang H.   +5 more
europepmc   +1 more source